translational research - search results

OAG highlights the efforts made by the Welsh Government to improve cancer care and research throughout the country Due to an ageing population, the demand for cancer care is ever increasing. In Wales, cancer is one of the two biggest causes of premature death, which is why tackling the disease...

Dinesen L1, 2, Poots AJ1, Bell D1, 2. 1.NIHR CLAHRC NW London, Imperial College London 2.Dept. Acute Medicine, Chelsea and Westminster Hospital What is Acute Medicine? Acute medicine is the part of internal medicine concerned with the immediate and early specialist management of adult patients who present to, or from within,...

Launched with an investment of €18 million, the UCD Charles Institute for Translational Dermatology is the first academic institute devoted to translational dermatology in Ireland and Europe. The Institute’s vision is to become a world leader in translational dermatology research, supporting optimal patient care in Ireland, and to establish...

Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.

Kapil Bharti, PhD, Senior Investigator and Head of the Ocular and Stem Cell Translational Research Section at the National Eye Institute (NEI), explains testing the safety of a stem cell therapy for age-related macular degeneration in this special focus on eye health.

Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.

Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.

Mohammed Gbadamosi and Jatinder K Lamba from Department of Pharmacotherapy and Translational Research at the University of Florida explain CD33-directed therapy for acute myeloid leukaemia (AML), focussing on current and future perspectives

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research explores the current progress in Acute Myeloid Leukaemia (AML)

Pharma researchers Julie Blaising and Philip Smith from F. Hoffmann-La Roche Ltd. discuss the endocannabinoid system as a pathway to treat inflammatory diseases such as Inflammatory Bowel Disease (IBD) and endometriosis.

Jean Pfau received her Ph.D. in Microbiology/Biochemistry at the University of Montana Her post-doctoral training fostered her true passion for inflammatory and autoimmune diseases, which became her research focus. In 2001, Dr. Pfau joined a distinguished team of researchers from around the country to explore the health effects of asbestos,...

We invite you to review North America Analysis’s Autumn edition, which offers valuable insights from a wide range of respected subject matter experts and researchers.

Oxygen (O2) transport and hemostasis are central to human adaptation to stress/injury and to disease pathobiology.

Eric Buckland, PhD of Translational Imaging Innovations, delves into how we can achieve better transparency, traceability, and reproducibility in AI/ML for ophthalmology and medicine.

Imperial College London opens its first-ever centre designing prosthetic innovations for child blast injuries occurring in conflict zones.

Eric Buckland of Translational Imaging Innovations looks at ophthalmic drug development and how better clinical endpoints can improve success rates.

In this eBook, Sabine Mai from the University of Manitoba explores how nuclear architecture enables the analysis of genomic instability in cancer.

Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.

European Brain Council outlines the priorities for the future when it comes to improving the lives of people with brain disorders.